395 related articles for article (PubMed ID: 7897208)
61. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
[TBL] [Abstract][Full Text] [Related]
62. Regulation of HLA class II molecule expressions by IFN-gamma. The signal transduction mechanism in glioblastoma cell lines.
Nezu N; Ryu K; Koide Y; Yoshida TO
J Immunol; 1990 Nov; 145(9):3126-35. PubMed ID: 2212676
[TBL] [Abstract][Full Text] [Related]
63. Regulation of cellular gene expression by interferon-gamma: involvement of multiple pathways.
Gupta SL
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():92-102. PubMed ID: 2109025
[TBL] [Abstract][Full Text] [Related]
64. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
[TBL] [Abstract][Full Text] [Related]
65. Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.
Stam NJ; Kast WM; Voordouw AC; Pastoors LB; van der Hoeven FA; Melief CJ; Ploegh HL
J Immunol; 1989 Jun; 142(11):4113-7. PubMed ID: 2541206
[TBL] [Abstract][Full Text] [Related]
66. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions.
Savage CO; Hughes CC; McIntyre BW; Picard JK; Pober JS
Transplantation; 1993 Jul; 56(1):128-34. PubMed ID: 7687392
[TBL] [Abstract][Full Text] [Related]
67. Binding of nuclear factors to the IFN-gamma consensus sequence of the human HLA-DR alpha gene: effects of IFN-gamma on tumor cell lines.
Gambari R; Barbieri R; Nastruzzi C; Feriotto G; Piva R; Natali PG; Giacomini P
J Biol Regul Homeost Agents; 1990; 4(3):98-106. PubMed ID: 2135380
[TBL] [Abstract][Full Text] [Related]
68. Usage of primary cells to delineate IFN-gamma-responsive DNA elements in the HLA-DRA promoter and to identify a novel IFN-gamma-enhanced nuclear factor.
Moses H; Panek RB; Benveniste EN; Ting JP
J Immunol; 1992 Jun; 148(11):3643-51. PubMed ID: 1588050
[TBL] [Abstract][Full Text] [Related]
69. Human immune responses to dengue viruses.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Rothman AL; Livingston PG; Janus J; Ennis FA
Southeast Asian J Trop Med Public Health; 1990 Dec; 21(4):658-62. PubMed ID: 1983049
[TBL] [Abstract][Full Text] [Related]
70. Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseases.
Miller A; Lanir N; Shapiro S; Revel M; Honigman S; Kinarty A; Lahat N
J Neuroimmunol; 1996 Feb; 64(2):151-61. PubMed ID: 8632057
[TBL] [Abstract][Full Text] [Related]
71. CD45-cross-linking stimulates IFN-gamma production in NK cells.
Shen F; Xu XL; Graf LH; Chong AS
J Immunol; 1995 Jan; 154(2):644-52. PubMed ID: 7814873
[TBL] [Abstract][Full Text] [Related]
72. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP
Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294
[TBL] [Abstract][Full Text] [Related]
73. Heterogeneous induction of major histocompatibility complex class II antigens on corneal endothelium by interferon-gamma.
Foets BJ; van den Oord JJ; Billiau A; Van Damme J; Missotten L
Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):341-5. PubMed ID: 1899654
[TBL] [Abstract][Full Text] [Related]
74. Differential up-regulation of HLA class I molecules on neuronal and glial cell lines by virus infection correlates with differential induction of IFN-beta.
Dhib-Jalbut SS; Xia Q; Drew PD; Swoveland PT
J Immunol; 1995 Aug; 155(4):2096-108. PubMed ID: 7636259
[TBL] [Abstract][Full Text] [Related]
75. Molecular analysis of HLA-DR gene expression induced by IFN-gamma in malignant melanoma cell lines.
Lee JL; Kim YH; Lee JM; Kim JD; Kim SJ; Park JH
Yonsei Med J; 1999 Feb; 40(1):30-9. PubMed ID: 10198604
[TBL] [Abstract][Full Text] [Related]
76. Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis.
Ayalon O; Hughes EA; Cresswell P; Lee J; O'Donnell L; Pardi R; Bender JR
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2435-40. PubMed ID: 9482903
[TBL] [Abstract][Full Text] [Related]
77. Interferon-gamma suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells.
Mond JJ; Carman J; Sarma C; Ohara J; Finkelman FD
J Immunol; 1986 Dec; 137(11):3534-7. PubMed ID: 3097125
[TBL] [Abstract][Full Text] [Related]
78. Recombinant interferon-gamma increases HLA-DR synthesis and expression.
Basham TY; Merigan TC
J Immunol; 1983 Apr; 130(4):1492-4. PubMed ID: 6403609
[TBL] [Abstract][Full Text] [Related]
79. Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas.
Pujol-Borrell R; Todd I; Doshi M; Gray D; Feldmann M; Bottazzo GF
Clin Exp Immunol; 1986 Jul; 65(1):128-39. PubMed ID: 3098471
[TBL] [Abstract][Full Text] [Related]
80. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
Santoli D; Francis MK; Matera L; Ferrero D
J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
